Rutgers researchers find titanium particles from dental implants can impair immune cell function

Dental implants have restored fixed, functional teeth for tens of millions of people worldwide, but 10% to 20% of recipients eventually develop peri-implantitis, an aggressive infection that damages surrounding jawbone and often resists antibiotics, according to researchers at Rutgers School of Dental Medicine (eurekalert.org).

A new study published in PNAS Nexus explains why treatments effective for similar infections around natural teeth frequently fail around implants. Bacteria form acidic biofilms on titanium implant surfaces that gradually corrode the metal, releasing billions of microscopic titanium particles smaller than a red blood cell into nearby gum tissues, as detailed in the Rutgers findings reported by ScienceDaily (sciencedaily.com). Particles can also be released during professional cleanings if abrasive metal instruments designed for natural teeth are used.

Once in the tissue, the titanium fragments attract and become coated with lipopolysaccharide, a bacterial toxin. This makes the particles appear to the immune system as oversized, indigestible bacteria. Macrophages, the immune cells that engulf pathogens, consume the particles but cannot break down the metal. The cells become locked in a prolonged hyperinflammatory state, releasing high levels of signaling molecules such as interleukin-1 beta, which is linked to other inflammatory conditions. This inflammation progressively destroys supporting jawbone while simultaneously impairing the macrophages’ ability to clear the original bacterial infection.

Laboratory tests showed that macrophages exposed to the titanium particles engulfed fewer than half as many bacteria as unexposed cells. “These particles are little magnets that attract the bacterial toxin, and they hijack the immune system, preventing it from clearing bacteria,” said senior author Georgios Kotsakis, assistant dean for clinical research at the Rutgers School of Dental Medicine, in the EurekAlert release (eurekalert.org). “You have a perfect storm that defies antibiotics.” The condition costs healthcare systems more than $1 billion annually worldwide.

The research team, using human tissue samples, cultured human immune cells, and genetically engineered mice, traced the disruptive pathway to TRPC1, a calcium channel in macrophage cell membranes. When mice lacking TRPC1 were exposed to the same combination of titanium particles and bacteria, they developed dramatically smaller abscesses, produced fewer inflammatory cytokines, and restored normal bacterial clearance. Disabling the channel prevented the destructive process.

The discovery identifies TRPC1 as the first credible drug target for peri-implantitis. Funded by the National Institutes of Health, the Kotsakis group is evaluating candidate drugs that act on this pathway in human cells, according to SciTechDaily coverage of the work (scitechdaily.com). The peer-reviewed paper is titled “Implant-derived titanium particles impair macrophage bacterial clearance via TRPC1 and lysosomal dysfunction” (DOI: 10.1093/pnasnexus/pgag081).

For current implant patients, the findings underscore the value of regular professional cleanings performed with nonabrasive techniques that avoid further damaging titanium surfaces. Metal scalers once commonly used on implants have been shown to promote corrosion and particle release; nonabrasive methods are now standard practice. The study provides a mechanistic explanation for antibiotic resistance in peri-implantitis and opens a path toward host-modulating therapies that restore immune competence rather than solely targeting bacteria.